AAAAAA

   
Results: 1-8 |
Results: 8
Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer
Authors: Boddy, AV Griffin, MJ Sludden, J Thomas, HD Fishwick, K Wright, JG Plummer, ER Highley, M Calvert, AH
Citation: Av. Boddy et al., Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer, CANC CHEMOT, 48(1), 2001, pp. 15-21
Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations
Authors: Morsman, JM Sludden, J Ameyaw, MM Githang'a, J Indalo, A Ofori-Adjei, D McLeod, HL
Citation: Jm. Morsman et al., Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations, BR J CL PH, 50(3), 2000, pp. 269-272
The encapsulation of bleomycin within chitosan based polymeric vesicles does not alter its biodistribution
Authors: Sludden, J Uchegbu, IF Schatzlein, AG
Citation: J. Sludden et al., The encapsulation of bleomycin within chitosan based polymeric vesicles does not alter its biodistribution, J PHARM PHA, 52(4), 2000, pp. 377-382
Reversal of drug resistance in human tumor xenografts by 2 '-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter
Authors: Plumb, JA Strathdee, G Sludden, J Kaye, SB Brown, R
Citation: Ja. Plumb et al., Reversal of drug resistance in human tumor xenografts by 2 '-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter, CANCER RES, 60(21), 2000, pp. 6039-6044
The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations
Authors: Collie-Duguid, ESR Pritchard, SC Powrie, RH Sludden, J Collier, DA Li, T McLeod, HL
Citation: Esr. Collie-duguid et al., The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations, PHARMACOGEN, 9(1), 1999, pp. 37-42
Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
Authors: Stevenson, JP DeMaria, D Sludden, J Kaye, SB Paz-Ares, L Grochow, LB McDonald, A Selinger, K Wissel, P O'Dwyer, PJ Twelves, C
Citation: Jp. Stevenson et al., Phase I pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion, ANN ONCOL, 10(3), 1999, pp. 339-344
Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
Authors: Twelves, CJ Gardner, C Flavin, A Sludden, J Dennis, I de Bono, J Beale, P Vasey, P Hutchison, C Macham, MA Rodriguez, A Judson, I Bleehen, NM
Citation: Cj. Twelves et al., Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II, BR J CANC, 80(11), 1999, pp. 1786-1791
Polymeric chitosan-based vesicles for drug delivery
Authors: Uchegbu, IF Schatzlein, AG Tetley, L Gray, AI Sludden, J Siddique, S Mosha, E
Citation: If. Uchegbu et al., Polymeric chitosan-based vesicles for drug delivery, J PHARM PHA, 50(5), 1998, pp. 453-458
Risultati: 1-8 |